Preface Biological therapies for Inflammatory Bowel Diseases: Are we finally going to modify the disease course ?
| Journal | Volume 64 - 2001 |
| Issue | Fasc.2 - Symposium |
| Author(s) | Paul Rutgeerts |
| Full article |
 VIEW FREE PDF |
|
It is clear that the introduction of immunomodulation therapy, especially with the chimeric monoclonal antiTNF antibody, in the past five years is thoroughly changing our approach to the treatment of inflammatory bowel disease (IBD). This novel therapy emerges at a time that immunosuppression with azathioprine finally gained wide acceptance for the treatment of Crohn's disease and ulcerative colitis.3 |
|
© Acta Gastro-Enterologica Belgica. |
